Disarticulation of a knee joint in a haemophiliac with high inhibitor titre

被引:8
作者
Chuansumrit, A
Hathirat, P
Keorochana, S
Tardtong, P
Pintadit, P
Rueangwetsawat, Y
Isarangkura, P
机构
[1] Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok
关键词
continuous infusion cryoprecipitate; factor VIII concentrate; haemophilia A; high inhibitor titre; surgery;
D O I
10.1111/j.1365-2516.1996.tb00027.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disarticulation of a knee joint in an 8-year-old haemophilia A patient with high inhibitor of 3450 Bethesda units (BU) is described. He had an infected compound fracture of the tibia and fibula. Surgery was successfully performed after extensive plasma exchange; administration of immunosuppressive agents such as cyclophosphamide, methylprednisolone, intravenous immunoglobulin and cyclosporine were combined with a loading dose of 100 units kg(-1) of factor VIII concentrate, followed by continuous infusion of 16 units kg(-1) h(-1) of factor VIII in the form of factor VIII concentrate and cryoprecipitate for 7 days and decreased to 8 units kg(-1) h(-1) in the form of cryoprecipitate for 19 more days. During the Ist to 7th post-operative days, the lowest factor VIII inhibitor was 18 BU and the factor VIII level ranged from < 1-2.1 IU dL(-1). On the 9th and 13th post-operative day, although the inhibitor rose to 330 and 2700 BU, respectively, there was no serious bleeding. The suture was removed on the 21st post-operative day. The inhibitor spontaneously decreased to 550, 232 and 14 BU at 1, 7 and 10 months, respectively.
引用
收藏
页码:116 / 119
页数:4
相关论文
共 11 条
[1]  
BRACKMANN HH, 1982, ACTIVATED PROTHROMBI, P194
[2]  
Chuansumrit Ampaiwan, 1993, Journal of the Medical Association of Thailand, V76, P92
[3]   LOCALIZATION OF HUMAN FACTOR-FVIII INHIBITOR EPITOPES TO 2 POLYPEPTIDE FRAGMENTS [J].
FULCHER, CA ;
MAHONEY, SD ;
ROBERTS, JR ;
KASPER, CK ;
ZIMMERMAN, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (22) :7728-7732
[4]  
HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
[5]   COMPARISON OF CONTINUOUS AND INTERMITTENT FACTOR-VIII CONCENTRATE THERAPY IN HEMOPHILIA-A [J].
HATHAWAY, WE ;
CHRISTIAN, MJ ;
CLARKE, SL ;
HASIBA, U .
AMERICAN JOURNAL OF HEMATOLOGY, 1984, 17 (01) :85-88
[6]  
KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869
[7]   DOMICILIARY DESENSITIZATION THERAPY FOR YOUNG BOYS WITH HEMOPHILIA AND FACTOR-VIII INHIBITORS [J].
LILLEYMAN, JS .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) :433-435
[8]   ADJUSTED DOSE CONTINUOUS INFUSION OF FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A [J].
MARTINOWITZ, U ;
SCHULMAN, S ;
GITEL, S ;
HOROZOWSKI, H ;
HEIM, M ;
VARON, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (04) :729-734
[9]   INDUCTION OF IMMUNE TOLERANCE IN PATIENTS WITH HEMOPHILIA AND ANTIBODIES TO FACTOR-VIII BY COMBINED TREATMENT WITH INTRAVENOUS IGG, CYCLOPHOSPHAMIDE, AND FACTOR-VIII [J].
NILSSON, IM ;
BERNTORP, E ;
ZETTERVALL, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (15) :947-950
[10]  
SHAPIRO S S, 1975, Seminars in Thrombosis and Hemostasis, V1, P336